- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03592719
Motivational Interviewing to Increase PrEP Uptake (MI-PrEP) (MI-PrEP)
December 16, 2020 updated by: Sannisha K Dale, University of Miami
The purpose of this study is to test a counseling program for Black women at high risk for HIV
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- HIV-negative
- Identify as Black and/or African American
- Age 18 or older
- Cis-gender Female
- English speaking
- Is capable of completing and fully understanding the informed consent process and the study procedures and
- Meets the Center for Disease Control's indications for PrEP use (17): (a) any sex with opposite sex partners in the past 6 months and (b) not in a monogamous partnership with a recently tested HIV-negative partner or (c) any injection of drugs not prescribed by a clinician in the past 6 months AND (d) at least one of the following: (i) infrequently uses condoms in sex with one/more partners of unknown HIV status (ii) in a sexual relationship with an HIV-positive partner or (iii) any sharing of injection/drug preparation equipment in past 6 months.
Exclusion Criteria:
- Not capable of completing/fully understanding the consent process and the study procedures.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MI-PrEP
Participants in this arm will receive the manualized two-session intervention entitled "Motivational Interviewing to Increase PrEP Uptake"
|
The experimental intervention will consist of two sessions.
The first session will involve psycho-education on PrEP and Motivational Interviewing to explore ambivalence about PrEP uptake.
The second session will involve Motivational Interviewing and case management to explore barriers to accessing PrEP.
Other Names:
|
Active Comparator: Enhanced Treatment as Usual (E-TAU)
Participants in this arm will receive two sessions which entail psychoeducation on PrEP.
|
Participants assigned to the control condition will receive two sessions, both of which involve psychoeducation on PrEP.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Motivation for PrEP
Time Frame: Baseline, Up to 6 weeks
|
Motivation to use PrEP will be measured with the Contemplation Ladder and the Readiness Ruler, which assess intention to use PrEP and the perceived importance of using PrEP.
The Contemplation Ladder and the Readiness Ruler each have a total score range from 0 to 10. Higher scores on the Contemplation Ladder indicate higher levels of contemplation or consideration about PrEP use.
Higher scores on the Readiness Ruler indicate higher perceived importance of starting PrEP.
|
Baseline, Up to 6 weeks
|
Change in PrEP uptake
Time Frame: Baseline, Up to 6 weeks
|
PrEP uptake will be verified by the participants' providers.
|
Baseline, Up to 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Knowledge of PrEP
Time Frame: Baseline, Up to 6 weeks
|
Knowledge of PrEP will be measured using a PrEP fact sheet, with basic information about PrEP.
The PrEP Fact Sheet has a total score range of 0 to 12, with higher scores indicating higher levels of PrEP knowledge.
|
Baseline, Up to 6 weeks
|
Change in Barriers for PrEP
Time Frame: Baseline, Up to 6 weeks
|
Perceived barriers to PrEP uptake/usage will be measured by an adapted version of the Barriers to Care Scale, in which participants are asked about factors that make it difficult to receive PrEP related services.
The Barriers to Care scale has a total score range of 7 to 28, with higher scores indicating increased difficulty regarding barriers to PrEP uptake.
|
Baseline, Up to 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Actual)
November 11, 2019
Study Completion (Actual)
November 11, 2019
Study Registration Dates
First Submitted
July 9, 2018
First Submitted That Met QC Criteria
July 9, 2018
First Posted (Actual)
July 19, 2018
Study Record Updates
Last Update Posted (Actual)
December 19, 2020
Last Update Submitted That Met QC Criteria
December 16, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 20180516
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
Assistance Publique - Hôpitaux de ParisDirection Générale de l'Offre de SoinsCompleted
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityNorthShore University HealthSystem; Case Western Reserve University; Shirley... and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
University of DelawareCompleted
Clinical Trials on Experimental Intervention (MI-PrEP)
-
Richard CrosbyUniversity of Mississippi Medical CenterCompleted
-
Massachusetts General HospitalRecruitingHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IUnited States
-
University of California, San FranciscoNational Institute of Nursing Research (NINR); San Francisco Department of...CompletedHIV/AIDSUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
Karolinska InstitutetCompletedPatient Satisfaction and Efficacy of Bowel-preparationSweden
-
Rhode Island HospitalUniversity of Mississippi Medical CenterRecruiting
-
Massachusetts General HospitalActive, not recruitingDeveloping a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: RCTMetabolic SyndromeUnited States
-
University of Wisconsin, MadisonVirginia Commonwealth UniversityRecruitingDevelopmental DisabilityUnited States
-
The University of Hong KongRecruitingOlder Adults | Advance Care Planning | Family Members | Advance DirectivesHong Kong
-
Massachusetts General HospitalCompletedMetabolic SyndromeUnited States